Pura Vida Investments, LLC Poseida Therapeutics, Inc. Transaction History

Pura Vida Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.22 - $7.04 $289,432 - $632,797	-89,886 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$6.23 - $7.6 $152,367 - $185,873	-24,457 Reduced 21.39%	89,886 $612,000
Q3 2021 Nov 15, 2021	SELL	$7.09 - $10.71 $204,028 - $308,201	-28,777 Reduced 20.11%	114,343 $834,000
Q2 2021 Aug 16, 2021	SELL	$7.96 - $10.07 $741,800 - $938,433	-93,191 Reduced 39.44%	143,120 $1.43 Million
Q1 2021 May 12, 2021	BUY	$8.51 - $11.91 $2.01 Million - $2.81 Million	236,311 New	236,311 $2.26 Million
Q4 2020 Feb 16, 2021	SELL	$8.29 - $11.7 $1.23 Million - $1.74 Million	-148,949 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$8.09 - $16.25 $1.2 Million - $2.42 Million	148,949 New	148,949 $1.32 Million

38.5M

377K

22.2K

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $810M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.